Personal information

No personal information available

Activities

Collapse all

Works (9)

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?

Current oncology reports
2024-08-08 | Journal article
DOI: 10.1007/s11912-024-01587-6
PMID: 39115678
Contributors: Rodriguez IV; Ghezelayagh T; Pennington KP; Norquist BM
Source: Self-asserted source
Isabel Rodriguez

Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN
2024-04-18 | Journal article
DOI: 10.6004/jnccn.2023.7331
PMID: 38866043
Contributors: Manchanda R; Sun L; Sobocan M; Rodriguez IV; Wei X; Kalra A; Samuel Oxley; Sideris M; Fierheller CT; Robert Morgan et al.
Source: Self-asserted source
Isabel Rodriguez

Adoption of Universal Testing in Endometrial Cancers for Microsatellite Instability Using Next-Generation Sequencing.

JCO precision oncology
2023-09-01 | Journal article | Author
DOI: 10.1200/po.23.00033
PMID: 37856764
Contributors: Isabel Rodriguez; Sarah Strickland; Wells D; Manhardt E; Eric Konnick; Garcia R; Swisher E; Mark Kilgore; Barbara Norquist
Source: Self-asserted source
Isabel Rodriguez

Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas.

Science translational medicine
2022-07-06 | Journal article | Author
DOI: 10.1126/scitranslmed.abn1926
PMID: 35857626
PMC: PMC9585706
Contributors: francesca menghi; Kalyan Banda; Pooja Kumar; Robert Straub; Lacey Dobrolecki; Isabel Rodriguez; Susan Yost; Harshpreet Chandok; Marc R Radke; Somlo G et al.
Source: Self-asserted source
Isabel Rodriguez

Development and Validation of a Model for Opioid Prescribing Following Gynecological Surgery.

JAMA network open
2022-07-01 | Journal article
DOI: 10.1001/jamanetworkopen.2022.22973
PMID: 35857323
PMC: PMC9301519
Contributors: Rodriguez IV; Cisa PM; Monuszko K; Salinaro J; Habib AS; Jelovsek JE; Havrilesky LJ; Davidson B
Source: Self-asserted source
Isabel Rodriguez

Impact of SARS-CoV-2 on training and mental well-being of surgical gynecological oncology trainees.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
2021-07-29 | Journal article
DOI: 10.1136/ijgc-2021-002803
PMID: 34326158
Contributors: Faiza Gaba; Blyuss O; Rodriguez I; Dilley J; Yee-Loi Wan; Saiz A; Zoia Razumova; Zalewski K; Nikolova T; Selcuk I et al.
Source: Self-asserted source
Isabel Rodriguez

Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance.

Frontiers in oncology
2021-03-22 | Journal article
DOI: 10.3389/fonc.2021.620873
PMID: 33828978
PMC: PMC8019902
Contributors: Visco ZR; Sfakianos G; Grenier C; Boudreau MH; Simpson S; Rodriguez I; Whitaker R; Yao DY; Berchuck A; Susan K. Murphy et al.
Source: Self-asserted source
Isabel Rodriguez

Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.

Oncotarget
2016-11-01 | Journal article
DOI: 10.18632/oncotarget.12725
PMID: 27769055
PMC: PMC5363606
Contributors: Bokhari AA; Lee LR; Raboteau D; Turbov J; Rodriguez IV; Pike JW; Hamilton CA; Maxwell GL; Rodriguez GC; Syed V
Source: Self-asserted source
Isabel Rodriguez

Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention.

Gynecologic oncology
2016-07-29 | Journal article
DOI: 10.1016/j.ygyno.2016.04.022
PMID: 27106018
Contributors: Rodriguez GC; Turbov J; Rosales R; Yoo J; Hunn J; Katherine Zappia; Lund K; Barry CP; Rodriguez IV; Pike JW et al.
Source: Self-asserted source
Isabel Rodriguez
How many people are using ORCID?